Targeted therapy focuses on specific molecules and pathways crucial to cancer cell survival and proliferation. Drugs like tyrosine kinase inhibitors and monoclonal antibodies are designed to interfere with these targets, offering a more precise attack on cancer cells while sparing healthy tissue.
